Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Emulate is raising $82,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Jim Corbett played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Emulate
Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System includes three components: Zoe Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease, offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection and have also been awarded Product Design of the Year 2015 by Londons Design Museum.

To learn more about Emulate, visit http://www.emulatebio.com/

Contact:
Jim Corbett, Chief Executive Officer
617-704-9222
https://www.linkedin.com/in/jcorbettvh/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved